Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.06315
+0.0015 (2.37%)
Sep 25, 2026, 2:20 PM EST
Emmaus Life Sciences Employees
As of December 31, 2025, Emmaus Life Sciences had 33 total employees, including 32 full-time and 1 part-time employees. The number of employees decreased by 2 or -5.71% compared to the previous year.
Employees
33
Change (1Y)
-2
Growth (1Y)
-5.71%
Revenue / Employee
$470,606
Profits / Employee
-$182,515
Market Cap
4.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 33 | -2 | -5.71% | 32 | 1 |
| Dec 31, 2024 | 35 | -20 | -36.36% | 34 | 1 |
| Dec 31, 2023 | 55 | 0 | - | 51 | 4 |
| Dec 31, 2022 | 55 | -7 | -11.29% | 54 | 1 |
| Dec 31, 2021 | 62 | 4 | 6.90% | 58 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 272 |
| Orgenesis | 77 |
| BioAtla | 41 |
| Reviva Pharmaceuticals Holdings | 14 |
| America Great Health | 5 |
Emmaus Life Sciences News
- 25 days ago - Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer - Business Wire
- 6 weeks ago - Emmaus Life Sciences Reports Quarterly Financial Results - Business Wire
- 5 months ago - Emmaus Life Sciences Reports Annual Financial Results - Business Wire
- 8 months ago - Emmaus Life Sciences enters license, distribution agreement with NeoImmuneTech - TheFly
- 8 months ago - Emmaus Life Sciences Announces Strategic Transaction - Business Wire
- 1 year ago - Emmaus Life Sciences receives FDA approval for Endari label changes - TheFly
- 1 year ago - Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Improved Quarterly Financial Results - PRNewsWire